共 50 条
- [1] DEC methods for appraising new drugs - Are a foundation for the NICE appraisal committee BRITISH MEDICAL JOURNAL, 1999, 319 (7215): : 1005 - 1005
- [2] Not playing with a full DEC: why development and evaluation committee methods for appraising new drugs may be inadequate BRITISH MEDICAL JOURNAL, 1999, 318 (7196): : 1480 - 1482
- [3] Not playing with a full DEC: why development and evaluation committee methods for appraising new drugs may be inadequate (vol 318, pg 1480, 1999) BRITISH MEDICAL JOURNAL, 1999, 319 (7203): : 185 - 185
- [4] Development and evaluation committees' methods for appraising new drugs - Reply by members of committee BRITISH MEDICAL JOURNAL, 2000, 320 (7236): : 715 - 715
- [5] NEW METHODS OF APPRAISING GOVERNMENT EXPENDITURE - ECONOMIC ANALYSIS PUBLIC FINANCE-FINANCES PUBLIQUES, 1972, 27 (02): : 85 - 91
- [9] Is concern about cardiovascular events with the new coxib class of drugs justified? MEDSCAPE WOMENS HEALTH, 2001, 6 (05):
- [10] Efficacy, safety, and cost of new anticancer drugs - Pessimistic conclusion was not justified BMJ-BRITISH MEDICAL JOURNAL, 2002, 325 (7375): : 1302 - 1303